🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06877481
Recruiting Observational

Turkish Validation of the Geriatric Pain Measure - Short Form

NCT06877481 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-03-15
Last updated
2025-03-20

Condition(s) studied

Geriatric AssessmentPain MeasurementChronic Pain

Investigational drug(s) / intervention(s)

Geriatric Pain Measurement Short Form

Geriatric Pain Measurement Short Form: Geriatric Pain Measure - Short Form (GPM-SF) is a validated pain assessment tool designed specifically for older adults. It is a 12-item questionnaire that evaluates pain intensity, interference with daily activities, and emotional impact of chronic pain in geriatric patients. The short form provides a quick and reliable assessment of pain-related disability in older populations.

Study summary

This study aims to adapt, validate, and assess the reliability of the Geriatric Pain Measure - Short Form in Turkish. A total of 150 patients aged 65 years and older will complete the scale under the supervision of pain management and gerontology specialists. Reliability and validity will be evaluated using statistical analyses, including internal consistency, test-retest reliability, and correlation with validated pain and sleep scales. Ethical approval has been obtained, and all participants will provide informed consent.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Geriatric patients with chronic pain * Patients who agreed to participate in the study Exclusion Criteria: * Demantia * Mental of physical disorders that effect patients answering the scales * Diagnosis of malignancy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Başakşehir Çam and Sakura City Hospital Istanbul Başakşehir Recruiting

More Başakşehir Çam & Sakura City Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06877481 on ClinicalTrials.gov ↗ ← All trials in Turkey